Inhibiting the cGAS‐STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency‐induced DNA damage response
Open Access
- 22 June 2024
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 14 (6)
Abstract
Background: Myeloid cells play critical roles in the regulation of myocardial injury and repair. Clonal hematopoiesis (CH)‐related mutations in genes, such as Ten‐eleven Translocation 2 (TET2), can impair myeloid cells and are associated with increased risk of cardiovascular disease (CVD). How Tet2 loss‐of‐function (LOF) impacts myeloid cells and disrupts normal myocardial repair remains unclear.Methods: We established ischemia‐induced myocardial infarction (MI) in a myeloid‐specific Tet2‐deficient mouse model. The echocardiographic assessment was conducted to evaluate the cardiac function. Histological analysis was performed to evaluate morphological changes in infarcted areas and fibrosis. To monitor the dynamic changes of myeloid cells in cardiac tissues during cardiac remodeling after MI, we performed longitudinal analysis on subsets of myeloid cells using flow cytometry. We performed immunofluorescence (IF) staining to examine the DNA damage and genome instability caused by Tet2 LOF. Gene expression was assessed by real‐time qRT‐PCR. Stimulator of Interferon Genes (STING) pathway activation was assessed using various methods, including Western blotting, flow cytometry, ELISA and IF staining of key signaling proteins involved in this pathway. Additionally, H‐151 was used as a pharmacological tool to antagonize augmented STING activation in the murine MI model.Results: We observed a substantial increase of neutrophils in the post‐MI mice, which contributes to adverse outcomes during heart repair. Mechanistically, Tet2‐deficient myeloid cells exhibited increased genome instability, accompanied with augmented activation of the STING pathway. Furthermore, the use of H‐151 a covalent STING binder that targets the cysteine residue at position 91 and functions as a potent STING antagonist, led to a substantial decrease in neutrophil populations in Tet2‐deficient mice following myocardial infarction, thereby reversing adverse cardiac outcomes.Conclusion: Our novel findings establish the rationale for targeting the cGAS‐STING pathway as a promising therapeutic strategy to mitigate cardiovascular disease risk in individuals with clonal hematopoiesis harboring TET2 loss‐of‐function mutations.Highlights: Myeloid‐specific Tet2 depletion promotes neutrophil expansion upon myocardium infarction (MI); Tet2‐deficient myeloid cells exhibit increased genome instability and cGAS‐STING overactivation; STING antagonist H‐151 treatment reduces neutrophil expansion in Tet2‐deficient mice after MI and mitigates deleterious cardiac outcomes.Keywords
Funding Information
- National Institutes of Health (R35HL166557, R01DK132286, R01CA240258, R01CA232017, R21CA277257, HL169511, HL171574, HL118761)
- Welch Foundation (BE‐1913‐20220331)
- National Cancer Institute (R01CA232017, R01CA240258, R21CA277257)
- National Heart, Lung, and Blood Institute (R35HL166557)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK132286)
- Vivian L. Smith Foundation
This publication has 41 references indexed in Scilit:
- Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesisJournal of Experimental Medicine, 2012
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNAScience, 2011
- Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-CarboxylcytosineScience, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- Neutrophilia Predicts Death and Heart Failure After Myocardial InfarctionCirculation: Cardiovascular Quality and Outcomes, 2009
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functionsJournal of Experimental Medicine, 2007
- Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approachesJournal of Applied Physiology, 2007
- Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune ResponseImmunity, 2006
- Left Ventricular Remodeling After Myocardial InfarctionCirculation, 2000